128 related articles for article (PubMed ID: 21722017)
1. Erythropoietin and amyotrophic lateral sclerosis: Plasma level determination.
Carilho R; de Carvalho M; Kuehl U; Pinto S; Pinto A; Kromminga A; Costa J
Amyotroph Lateral Scler; 2011 Nov; 12(6):439-43. PubMed ID: 21722017
[TBL] [Abstract][Full Text] [Related]
2. Cerebrospinal fluid erythropoietin (EPO) in amyotrophic lateral sclerosis.
Brettschneider J; Widl K; Schattauer D; Ludolph AC; Tumani H
Neurosci Lett; 2007 Apr; 416(3):257-60. PubMed ID: 17368721
[TBL] [Abstract][Full Text] [Related]
3. Erythropoietin concentration in serum and cerebrospinal fluid of patients with amyotrophic lateral sclerosis.
Janik P; Kwiecinski H; Sokolowska B; Niebroj-Dobosz I
J Neural Transm (Vienna); 2010 Mar; 117(3):343-7. PubMed ID: 20012656
[TBL] [Abstract][Full Text] [Related]
4. Erythropoietin modulates the immune-inflammatory response of a SOD1(G93A) transgenic mouse model of amyotrophic lateral sclerosis (ALS).
Noh MY; Cho KA; Kim H; Kim SM; Kim SH
Neurosci Lett; 2014 Jun; 574():53-8. PubMed ID: 24820540
[TBL] [Abstract][Full Text] [Related]
5. Do bulbar-onset amyotrophic lateral sclerosis patients have an earlier respiratory involvement than spinal-onset amyotrophic lateral sclerosis patients?
Pinto S; Pinto A; De Carvalho M
Eura Medicophys; 2007 Dec; 43(4):505-9. PubMed ID: 18084174
[TBL] [Abstract][Full Text] [Related]
6. Respiratory muscle strength and ventilatory failure in amyotrophic lateral sclerosis.
Lyall RA; Donaldson N; Polkey MI; Leigh PN; Moxham J
Brain; 2001 Oct; 124(Pt 10):2000-13. PubMed ID: 11571218
[TBL] [Abstract][Full Text] [Related]
7. High erythropoietin and low vascular endothelial growth factor levels in cerebrospinal fluid from hypoxemic ALS patients suggest an abnormal response to hypoxia.
Just N; Moreau C; Lassalle P; Gosset P; Perez T; Brunaud-Danel V; Wallaert B; Destée A; Defebvre L; Tonnel AB; Devos D
Neuromuscul Disord; 2007 Feb; 17(2):169-73. PubMed ID: 17142042
[TBL] [Abstract][Full Text] [Related]
8. Amyotrophic lateral sclerosis: evaluation and treatment of respiratory impairment.
Lechtzin N; Rothstein J; Clawson L; Diette GB; Wiener CM
Amyotroph Lateral Scler Other Motor Neuron Disord; 2002 Mar; 3(1):5-13. PubMed ID: 12061943
[TBL] [Abstract][Full Text] [Related]
9. [Mechanisms of deregulated response to hypoxia in sporadic amyotrophic lateral sclerosis: a clinical study].
Moreau C; Devos D; Gosset P; Brunaud-Danel V; Tonnel AB; Lassalle P; Defebvre L; Destée A
Rev Neurol (Paris); 2010 Mar; 166(3):279-83. PubMed ID: 19660777
[TBL] [Abstract][Full Text] [Related]
10. [A study of bulbar, upper extremity, and lower extremity motor function preservation at the time that respiratory symptoms appear in ALS].
Kimura F; Fujimura C; Ishida S; Hosokawa T; Sato T; Nakajima H; Furutama D; Sugino M
Rinsho Shinkeigaku; 2007 Apr; 47(4):140-6. PubMed ID: 17511283
[TBL] [Abstract][Full Text] [Related]
11. [The changes of clinical characteristics in 100 Japanese amyotrophic lateral sclerosis patients between 1980 and 2000].
Kimura F; Shinoda K; Fujiwara S; Fujimura C; Nakajima H; Furutama D; Sugino M; Hanafusa T
Rinsho Shinkeigaku; 2003 Jul; 43(7):385-91. PubMed ID: 14582363
[TBL] [Abstract][Full Text] [Related]
12. Vascular endothelial growth factor and amyotrophic lateral sclerosis: the interplay with exercise and noninvasive ventilation.
Carilho R; de Carvalho M; Swash M; Pinto S; Pinto A; Costa J
Muscle Nerve; 2014 Apr; 49(4):545-50. PubMed ID: 23868282
[TBL] [Abstract][Full Text] [Related]
13. Plasma level of club-cell (CC-16) predicts outcome in amyotrophic lateral sclerosis.
Pronto-Laborinho AC; Gromicho M; Pereira M; Pinto S; Barros MDA; Swash M; de Carvalho M
Acta Neurol Scand; 2018 Feb; 137(2):233-237. PubMed ID: 28967121
[TBL] [Abstract][Full Text] [Related]
14. Erythropoietin in the cerebrospinal fluid in neurodegenerative diseases.
Brettschneider J; Widl K; Ehrenreich H; Riepe M; Tumani H
Neurosci Lett; 2006 Sep; 404(3):347-51. PubMed ID: 16815630
[TBL] [Abstract][Full Text] [Related]
15. Evaluation and management of respiratory muscle dysfunction in ALS.
Gregory SA
NeuroRehabilitation; 2007; 22(6):435-43. PubMed ID: 18198429
[TBL] [Abstract][Full Text] [Related]
16. Motor responses of the sternocleidomastoid muscle in patients with amyotrophic lateral sclerosis.
Pinto S; de Carvalho M
Muscle Nerve; 2008 Oct; 38(4):1312-7. PubMed ID: 18785186
[TBL] [Abstract][Full Text] [Related]
17. Bulbar impairment score predicts noninvasive volume-cycled ventilation failure during an acute lower respiratory tract infection in ALS.
Servera E; Sancho J; Bañuls P; Marín J
J Neurol Sci; 2015 Nov; 358(1-2):87-91. PubMed ID: 26329906
[TBL] [Abstract][Full Text] [Related]
18. CSF profiles of angiogenic and inflammatory factors depend on the respiratory status of ALS patients.
Moreau C; Gosset P; Brunaud-Danel V; Lassalle P; Degonne B; Destee A; Defebvre L; Devos D
Amyotroph Lateral Scler; 2009 Jun; 10(3):175-81. PubMed ID: 19177252
[TBL] [Abstract][Full Text] [Related]
19. Predictors of need for noninvasive ventilation during respiratory tract infections in medically stable, non-ventilated subjects with amyotrophic lateral sclerosis.
Sancho J; Servera E; Bañuls P; Marin J
Respir Care; 2015 Apr; 60(4):492-7. PubMed ID: 25406348
[TBL] [Abstract][Full Text] [Related]
20. Measuring vital capacity in amyotrophic lateral sclerosis: Effects of interfaces and reproducibility.
Pellegrino GM; Sferrazza Papa GF; Centanni S; Corbo M; Kvarnberg D; Tobin MJ; Laghi F
Respir Med; 2021 Jan; 176():106277. PubMed ID: 33310203
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
